Search results
2 High-Yield Dividend Stocks to Buy Right Now
The Motley Fool via AOL· 6 days agoHealthcare titans AbbVie (NYSE: ABBV) and Pfizer (NYSE: PFE) both offer shareholders stellar yields, historically cheap valuations, and a proven track...
The Income Investor's Dream Team: 7 Sturdy Dividend Stocks Yielding 6%
InvestorPlace· 7 days agoThe most obvious reason investors should buy high-yield dividend stocks is that they provide income....
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer
Motley Fool via Yahoo Finance· 7 days agoAt its beaten-down price, it offers an eye-popping 5.9% dividend yield. Pfizer has raised its ...
1 Beaten-Down S&P 500 Dividend Stock to Buy in June and Hold For a Decade or Longer | The Motley...
The Motley Fool· 7 days agoPfizer (PFE 0.61%) investors have been through a lot of ups and downs over the past few years....
7 High-Yield Dividend Stocks That Work While You Sleep
InvestorPlace· 7 days agoAlthough seemingly most of the celebrated ideas on financial publications center on high-growth...
2 Dividend Stocks Billionaires Are Buying: Should You? | The Motley Fool
The Motley Fool· 4 days agoMany billionaires are active on Wall Street and largely built their wealth that way. Of course,...
Weik Capital Management Sells 10,839 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 days agoThe institutional investor owned 30,315 shares of the biopharmaceutical company’s stock after selling 10,839 shares during the period. Weik Capital Management’s holdings in ...
3 Dividend Stocks You May Want To Double Down On
Benzinga via Yahoo Finance· 7 days agoSometimes, misunderstood stocks benefit investors. Savvy investors can capitalize when a stock is incorrectly perceived as weak during a recession....
7 Dividend Stocks to Invest In for a Lifetime of Income
InvestorPlace· 6 days agoFinally, the seventh one uses core competencies in financial performance, pipeline innovation, and cancer revenue growth. Without further ado, here are seven dividend stocks ...
Relay in clinical trial collaboration with Pfizer for breast cancer combo treatment
Seeking Alpha· 5 days agoRelay Therapeutics collaborates with Pfizer to investigate combination therapy for breast cancer using RLY-2608 and atirmociclib. Read more here.
